Description: Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Brentford, the United Kingdom.
Home Page: www.haleon.com
HLN Technical Analysis
Building 5
Weybridge,
KT13 0NY
United Kingdom
Phone:
44 1932 822000
Officers
| Name | Title |
|---|---|
| Mr. Brian McNamara | CEO & Exec. Director |
| Mr. Tobias Hestler | CFO & Exec. Director |
| Ms. Amy Landucci | Head of Digital and Technology |
| Mr. Bjarne Philip Tellmann | Gen. Counsel |
| Ms. Tamara Rogers | Chief Marketing Officer |
| Ms. Mairead Nayager | Chief HR Officer |
| Mr. Bart Derde | Head of Quality and Supply Chain |
| Mr. Filippo Lanzi | Head of EMEA & LatAm |
| Ms. Teri Lyng | Head of Transformation & Sustainability |
| Ms. Jooyong Lee | Head of Strategy and Office of the CEO |
Exchange: NYSE
Country: US
Currency: US Dollar ($)
| Forward PE: | 15.6986 |
|---|---|
| Trailing PE: | 21.7778 |
| Price-to-Book MRQ: | 1.0834 |
| Price-to-Sales TTM: | 3.3843 |
| IPO Date: | 2022-07-22 |
| Fiscal Year End: | December |
| Full Time Employees: | 22000 |